StockNews.com began coverage on shares of Exact Sciences ( NASDAQ:EXAS – Free Report ) in a report published on Thursday morning. The brokerage issued a hold rating on the medical research company's stock. EXAS has been the topic of several other research reports. Citigroup increased their price objective on Exact Sciences from $100.00 to $130.00 in a research report on Thursday, June 22nd. Jefferies Financial Group raised their price target on Exact Sciences from $100.00 to $110.00 and gave the stock a buy rating in a research report on Thursday, August 3rd.

https://www.dailypolitical.com/2023/08/18/exact-sciences-nasdaqexas-receives-new-coverage-from-analysts-at-stocknews-com.html

#dailypolitical